Cambridge Investment Research Advisors, Inc. Co Diagnostics, Inc. Transaction History

Cambridge Investment Research Advisors, Inc.

$29.4 Billion
Q3 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$1.39 - $3.24 $208 - $486	-150 Reduced 0.27%	54,866 $81,000
Q4 2022 Feb 08, 2023	SELL	$2.32 - $3.68 $23,200 - $36,800	-10,000 Reduced 15.38%	55,016 $139,000
Q3 2022 Oct 17, 2022	BUY	$2.87 - $7.01 $186,595 - $455,762	65,016 New	65,016 $0
Q2 2021 Aug 10, 2021	SELL	$7.16 - $9.56 $74,643 - $99,663	-10,425 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$8.52 - $19.21 $88,821 - $200,264	10,425 New	10,425 $99,000
Q3 2020 Oct 29, 2020	SELL	$8.24 - $30.8 $92,963 - $347,485	-11,282 Closed	0 $0
Q2 2020 Jul 27, 2020	BUY	$7.46 - $23.42 $84,163 - $264,224	11,282 New	11,282 $218,000

Others Institutions Holding CODX

# of Institutions

Shares Held

4.3M

Call Options Held

48.2K

Put Options Held

53.3K

Vanguard Group Inc Valley Forge, PA

1.78M
Shares

$1.89 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

568K
Shares

$601,785
0.0% of portfolio
Black Rock Inc. New York, NY

502K
Shares

$532,146
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

321K
Shares

$340,551
0.0% of portfolio
Bridgeway Capital Management, LLC Houston, TX

273K
Shares

$289,274
0.01% of portfolio

View Full List

About Co-Diagnostics, Inc.

Ticker CODX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 33,781,000
Market Cap $35.8M
Description
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...

More about CODX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account